Tempest Scrambles for Ways to Bankroll Late-Stage Liver Cancer Asset
According to Tempest, its options include a partnership or licensing deal, as well as a merger or an acquisition.
Tempest Scrambles for Ways to Bankroll Late-Stage Liver Cancer Asset Read More »
